In oculopharyngeal muscular dystrophy (OPMD), muscle strength slowly decreases due to a breakdown of muscle cells. Whereas OPMD may affect many muscles, the eyes (oculo) and the throat (pharynx) are disproportionately affected. OPMD is a hereditary muscle disease whose disease mechanism is not yet completely clear. The Biobank OPMD contains clinical data and residual biomaterial from a study where the efficacy of the protein degradation system was investigated in different cell models for OPMD. The study further examined whether recovery from degradation with the aid of medication resulted in less muscle weakness.
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Dutch-Nordic Alliance for Precision Cancer Medicine launched26 November 2021
The Nordic countries (Denmark, Sweden, Norway, and Finland) are together setting up national clinical precision cancer trials modelled on the very successful DRUP trial in the Netherlands.read more
New Automated PBMC isolation method introduced in LMI.21 September 2021
The Radboud Biobank (RB) and the laboratory of Medical Immunology (LMI) are making plans to replace the density gradient centrifugation method with a new automated PBMC isolation method, the AutoMACS Pro Separator.read more
Lysine Metabolism sub-biobank21 September 2021
Hereditary metabolic disorders form a large group of more than 1,400 rare disorders in which an error in the DNA causes abnormalities in the process in which proteins, fats and carbohydrates are converted into smaller building materials and energy.read more